Skip to content
  • Home
  • Named Patient Medicines
    • Oncology
      • Lung Cancer
        • IMDELLTRA (tarlatamab-dlle)
        • Alunbrig (Brigatinib)
        • Gavreto (pralsetinib)
        • Libtayo (cemiplimab-rwlc)
        • LUMAKRAS (Sotorasib)
        • Zepzelca (lurbinectedin)
      • Breast Cancer
        • Datroway (datopotamab deruxtecan-dlnk)
        • Talzenna (talazoparib)
        • Truqap (capivasertib)
        • Nerlynx (neratinib)
        • Orserdu (elacestrant)
      • Solid Tumors
        • PEMAZYRE (Pemigatinib)
        • Voranigo (vorasidenib)
        • Imjudo (tremelimumab)
        • Fotivda (tivozanib)
        • Tibosovo (ivosidenib)
        • Vyloy (zolbetuximab-clzb)
        • Fruzaqla (fruquintinib)
        • ERIVEDGE (Vismodegib)
        • Lytgobi (futibatinib)
        • Qinlock (ripretinib)
        • MEKTOVI (binimetinib)
        • BRAFTOVI (Encorafenib)
        • LYSODERN (Mitotane)
        • ZELBORAF (Vemurafenib)
        • Rozlytrek (entrectinib)
        • Vitrakvi (larotrectinib)
        • Padcev (enfortumab vedotin-ejfv)
        • Trodelvy (sacituzumab govitecan-hziy)
        • Zejula (niraparib)
        • Elahere (mirvetuximab soravtansine-gynx)
        • Ogsiveo (nirogacestat)
        • Revuforj (revumenib)
        • Onivyde (irinotecan hydrochloride trihydrate)
        • Ayvakit (avapritinib)
        • Opdualag (nivolumab and relatlimab)
        • Welireg (belzutifan)
        • Modeyso (dordaviprone)
      • Others
        • Rezurock (belumosudil)
        • Crysvita (burosumab)
    • Hematology
      • Talvey (talquetamab-tgvs)
      • Columvi (glofitamab-gxbm)
      • Ninlaro (ixazomib)
      • DAURISMO (Glasdegib)
      • Jaypirca (pirtobrutinib)
      • Vanflyta (quizartinib)
      • Xospata (gilteritinib)
      • Blenrep (belantamab mafodotin-blmf)
    • Rare Disease
      • Rinvoq (upadacitinib)
      • Spinraza (nusinersen)
      • Kevzara (sarilumab)
      • Ilaris (canakinumab)
      • Besremi (ropeginterferon alfa-2b)
      • Uplizna (inebilizumab-cdon)
      • Zeposia (ozanimod)
      • Ponvory (ponesimod)
      • Mavenclad (cladribine)
      • Tavneos (avacopan)
      • Tavlesse (fostamatinib)
      • Rilutek (riluzole)
      • Radicava ORS (edaravone)
      • Livmarli (maralixibat)
      • Cablivi (caplacizumab)
    • Miscellaneous
      • Givlaari (givosiran)
      • Tremfya (guselkumab)
      • Skyrizi (risankizumab)
  • Finished Formulation
  • API Supply
  • Blog
  • Contact Us

Request Medicine for NPP

    Upload Prescription

    Upload Patient Consent Form

    Patient Consent Form
    Download

    Please download and complete this form, including your signature, and attach it to the request form or email it to info@mitogene.org along with the patient details.

    • Home
    • API Supply
    • Finished Formulation
    • Legal Context
    • Contact Us
    • MitoGENE Blogs
    • WhatsApp
    • Facebook
    • YouTube
    • LinkedIn
    • Instagram
    • X

    Disclaimer: MitoGENE facilitates patient-specific access to medicines under Named Patient Program permitted by CDSCO through Form 12B import permit. The products mentioned are not approved for commercial sale in India. Access is strictly for personal use under physician supervision. Information provided on this website is sourced from publicly available references, and MitoGENE is not responsible for its completeness or accuracy. MitoGENE does not promote or sell unapproved drugs

    Contact us:

    Email: info@mitogene.org

    Phone: +91 9944424386,

    +91 99410 34386

    Address: No:7, Plot:47/1, Selvaraj Nagar, Extn – 2, Urapakkam West,

    Chennai – 603211

    © 2026 • Built with GeneratePress